Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Rajan

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
American Journal of Medical Genetics. Part A|February 25, 2022
Huriez syndrome: Additional pathogenic variants supporting allelism to SMARCAD syndromeAbigail Y T Loh, Sanja Špoljar, Granville Y W Neo, et al.
JAMA Dermatology|June 30, 2018
Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical TrialMarina Danilenko, Elaine Stamp, Deborah D Stocken, et al.
BMC Cancer|June 14, 2024
Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort studyAbigail Gault, Linda Hogarth, Kristian C Williams, et al.
The British Journal of Dermatology|March 4, 2026
Targeting non-canonical NF-κB signalling in CYLD cutaneous syndrome by selective inhibition of IκB kinase alphaKirsty Hodgson, Joseph Inns, Gary Reynolds, et al.
European Journal of Human Genetics : EJHG|July 31, 2024
ERN GENTURIS clinical practice guidelines for the diagnosis, surveillance and management of people with Birt-Hogg-Dubé syndromeMarianne Geilswijk, Maurizio Genuardi, Emma R Woodward, et al.
Oncotarget|January 24, 2022
Seventh BHD international symposium: recent scientific and clinical advancementMark R Woodford, Avgi Andreou, Masaya Baba, et al.
The Journal of Investigative Dermatology|May 15, 2026
CARMN fusions and PDGFRB mutations highlight key differences amongst cutaneous tumors with myopericytic differentiationMartin Del Castillo Velasco-Herrera, Saamin Cheema, Kim Wong, et al.
The British Journal of Dermatology|November 15, 2024
Exploring the genetic driver events of eccrine poromas and porocarcinomas: a retrospective, cross-institutional study of 54 casesMark J Arends, Martin Del Castillo Velasco-Herrera, Saamin Cheema, et al.
The British Journal of Dermatology|November 7, 2024
Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategyLouise van der Weyden, Martin Del Castillo Velasco-Herrera, Saamin Cheema, et al.
The Journal of Investigative Dermatology|December 25, 2022
PTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to MelanomaSatyamaanasa Polubothu, Nicole Bender, Siobhan Muthiah, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
American Journal of Medical Genetics. Part A|February 25, 2022
Huriez syndrome: Additional pathogenic variants supporting allelism to SMARCAD syndromeAbigail Y T Loh, Sanja Špoljar, Granville Y W Neo, et al.
JAMA Dermatology|June 30, 2018
Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical TrialMarina Danilenko, Elaine Stamp, Deborah D Stocken, et al.
BMC Cancer|June 14, 2024
Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort studyAbigail Gault, Linda Hogarth, Kristian C Williams, et al.
The British Journal of Dermatology|March 4, 2026
Targeting non-canonical NF-κB signalling in CYLD cutaneous syndrome by selective inhibition of IκB kinase alphaKirsty Hodgson, Joseph Inns, Gary Reynolds, et al.
European Journal of Human Genetics : EJHG|July 31, 2024
ERN GENTURIS clinical practice guidelines for the diagnosis, surveillance and management of people with Birt-Hogg-Dubé syndromeMarianne Geilswijk, Maurizio Genuardi, Emma R Woodward, et al.
Oncotarget|January 24, 2022
Seventh BHD international symposium: recent scientific and clinical advancementMark R Woodford, Avgi Andreou, Masaya Baba, et al.
The Journal of Investigative Dermatology|May 15, 2026
CARMN fusions and PDGFRB mutations highlight key differences amongst cutaneous tumors with myopericytic differentiationMartin Del Castillo Velasco-Herrera, Saamin Cheema, Kim Wong, et al.
The British Journal of Dermatology|November 15, 2024
Exploring the genetic driver events of eccrine poromas and porocarcinomas: a retrospective, cross-institutional study of 54 casesMark J Arends, Martin Del Castillo Velasco-Herrera, Saamin Cheema, et al.
The British Journal of Dermatology|November 7, 2024
Exploration of the mutational landscape of cutaneous leiomyoma confirms FH as a driver gene and identifies targeting purine metabolism as a potential therapeutic strategyLouise van der Weyden, Martin Del Castillo Velasco-Herrera, Saamin Cheema, et al.
The Journal of Investigative Dermatology|December 25, 2022
PTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to MelanomaSatyamaanasa Polubothu, Nicole Bender, Siobhan Muthiah, et al.
Pageof 10